Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Eicosanoids
Bruce D. Hammock, Weicang Wang, Molly M. Gilligan, et al.
American Journal Of Pathology (2020) Vol. 190, Iss. 9, pp. 1782-1788
Open Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Risk factors for severe and critically ill COVID‐19 patients: A review
Yadong Gao, Mei Ding, Xiang Dong, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 428-455
Open Access | Times Cited: 1282
Resolution of inflammation: An organizing principle in biology and medicine
Dipak Panigrahy, Molly M. Gilligan, Charles N. Serhan, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107879-107879
Closed Access | Times Cited: 232
Carcinogenesis: Failure of resolution of inflammation?
Anna Fishbein, Bruce D. Hammock, Charles N. Serhan, et al.
Pharmacology & Therapeutics (2020) Vol. 218, pp. 107670-107670
Open Access | Times Cited: 161
Producing Omega-3 Polyunsaturated Fatty Acids: A Review of Sustainable Sources and Future Trends for the EPA and DHA Market
Laura Oliver, T. Dietrich, Izaskun Marañón, et al.
Resources (2020) Vol. 9, Iss. 12, pp. 148-148
Open Access | Times Cited: 142
Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative
Bruce D. Hammock, Cindy B. McReynolds, Karen Wagner, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 4, pp. 1856-1872
Open Access | Times Cited: 103
NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase
Oluwafunke R. Kolawole, Khosrow Kashfi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1432-1432
Open Access | Times Cited: 81
Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19
Guohui Xue, Xing Gan, Zhìqiáng Wú, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107065-107065
Open Access | Times Cited: 104
Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets
Zhiqiang Pang, Guangyan Zhou, Jasmine Chong, et al.
Metabolites (2021) Vol. 11, Iss. 1, pp. 44-44
Open Access | Times Cited: 95
Thiophene-Based Compounds with Potential Anti-Inflammatory Activity
Ryldene Marques Duarte da Cruz, Francisco Jaime Bezerra Mendonça, Natália Barbosa de Mélo, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 692-692
Open Access | Times Cited: 70
The roles of lipids in SARS-CoV-2 viral replication and the host immune response
Katherine N. Theken, Soon Yew Tang, Shaon Sengupta, et al.
Journal of Lipid Research (2021) Vol. 62, pp. 100129-100129
Open Access | Times Cited: 70
Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial
Hildur Arnardottir, Sven‐Christian Pawelzik, Ulf Öhlund Wistbacka, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 66
Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages
Sina Bohnacker, Franziska Hartung, Fiona Henkel, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 3, pp. 515-524
Open Access | Times Cited: 54
Eicosanoids in inflammation in the blood and the vessel
Adriana Yamaguchi, Eliana Botta, Michael Holinstat
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 53
Is depression the missing link between inflammatory mediators and cancer?
Barbara Polityńska, Olga Pokorska, Anna M. Wojtukiewicz, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108293-108293
Closed Access | Times Cited: 39
Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase
Abigail G. Kelly, Weicang Wang, Eva Rothenberger, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 7
Open Access | Times Cited: 9
Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?
Ahmed M. Darwesh, Wesam Bassiouni, Deanna K. Sosnowski, et al.
Pharmacology & Therapeutics (2020) Vol. 219, pp. 107703-107703
Open Access | Times Cited: 62
The Role of Thromboxane in the Course and Treatment of Ischemic Stroke: Review
Małgorzata Szczuko, Igor Kozioł, Dariusz Kotlęga, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11644-11644
Open Access | Times Cited: 52
Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections
Cindy B. McReynolds, Irene Cortés‐Puch, Resmi Ravindran, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 51
Coronavirus-Induced Host Cubic Membranes and Lipid-Related Antiviral Therapies: A Focus on Bioactive Plasmalogens
Yuru Deng, Angelina Angelova
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 48
Alterations of Lipid Profile in COVID-19: A Narrative Review
Abbas Rezaei, Sina Neshat, Kiyan Heshmat‐Ghahdarijani
Current Problems in Cardiology (2021) Vol. 47, Iss. 3, pp. 100907-100907
Open Access | Times Cited: 47
COVID-19: Direct and Indirect Mechanisms of Statins
Agnieszka Pawlos, Mateusz Niedzielski, Paulina Gorzelak‐Pabiś, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4177-4177
Open Access | Times Cited: 45
Potential role of lipoxin in the management of COVID-19: a narrative review
Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 1993-2001
Open Access | Times Cited: 32
Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein
Oskar Staufer, Kapil Gupta, Jochen Estebano Hernandez Bücher, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Therapeutic strategy targeting host lipolysis limits infection by SARS-CoV-2 and influenza A virus
Yeong‐Bin Baek, Hyung‐Jun Kwon, Muhammad Anees Sharif, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 29
The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection
Claudio Gallo, Sirio Fiorino, Giovanni Posabella, et al.
Prostaglandins & Other Lipid Mediators (2022) Vol. 159, pp. 106619-106619
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top